Diabetes 72 , 599610 (2023)
Understanding the differences between available GLP-1 medications, their relative costs, and their clinical profiles helps you make the best choice for your situation
After 68 weeks of treatment with semaglutide 2.4 mg (the Wegovy dose, identical to the molecule in Ozempic), participants lost an average of 14.9% of their body weight
Sergey Terushkin, MD, FACS , a board-certified surgeon with experience in bariatric care, metabolic health, and physician-guided weight management
Rodriguez PJ, Zhang V, Gratzl S et al
The right approach depends on medical history, weight trajectory, body composition, side effects, cardiometabolic risk, medication access, and the patients ability to maintain nutrition and activity habits